- Home
- SRZN vs AXTI Comparison
SRZN vs AXTI Comparison
Compare SRZN & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- AXTI
- Stock Information
- Founded
- SRZN 2015
- AXTI 1986
- Country
- SRZN United States
- AXTI United States
- Employees
- SRZN N/A
- AXTI N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- AXTI Semiconductors
- Sector
- SRZN Health Care
- AXTI Technology
- Exchange
- SRZN Nasdaq
- AXTI Nasdaq
- Market Cap
- SRZN 97.3M
- AXTI 94.4M
- IPO Year
- SRZN N/A
- AXTI 1998
- Fundamental
- Price
- SRZN $12.55
- AXTI $2.94
- Analyst Decision
- SRZN Strong Buy
- AXTI Strong Buy
- Analyst Count
- SRZN 2
- AXTI 4
- Target Price
- SRZN $38.50
- AXTI $4.60
- AVG Volume (30 Days)
- SRZN 16.1K
- AXTI 623.7K
- Earning Date
- SRZN 08-08-2025
- AXTI 10-30-2025
- Dividend Yield
- SRZN N/A
- AXTI N/A
- EPS Growth
- SRZN N/A
- AXTI N/A
- EPS
- SRZN N/A
- AXTI N/A
- Revenue
- SRZN $12,621,000.00
- AXTI $86,080,000.00
- Revenue This Year
- SRZN N/A
- AXTI N/A
- Revenue Next Year
- SRZN N/A
- AXTI $31.28
- P/E Ratio
- SRZN N/A
- AXTI N/A
- Revenue Growth
- SRZN N/A
- AXTI N/A
- 52 Week Low
- SRZN $5.90
- AXTI $1.13
- 52 Week High
- SRZN $18.17
- AXTI $3.29
- Technical
- Relative Strength Index (RSI)
- SRZN 70.80
- AXTI 66.24
- Support Level
- SRZN $10.73
- AXTI $2.75
- Resistance Level
- SRZN $11.88
- AXTI $2.95
- Average True Range (ATR)
- SRZN 0.73
- AXTI 0.21
- MACD
- SRZN 0.09
- AXTI 0.07
- Stochastic Oscillator
- SRZN 74.09
- AXTI 80.65
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About AXTI AXT Inc
AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.